Rein Therapeutics, Inc. (RNTX)
0.791
-0.01
(-1.12%)
USD |
NASDAQ |
Sep 21, 16:00
0.791
0.00 (0.00%)
After-Hours: 20:00
Rein Therapeutics Price to Book Value : 6.652 for Sept. 21, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 6.727 |
| September 17, 2026 | 6.636 |
| September 16, 2026 | 5.904 |
| September 15, 2026 | 5.949 |
| September 14, 2026 | 6.652 |
| September 11, 2026 | 6.601 |
| September 10, 2026 | 6.567 |
| September 09, 2026 | 6.958 |
| September 08, 2026 | 7.253 |
| September 04, 2026 | 7.476 |
| September 03, 2026 | 7.094 |
| September 02, 2026 | 6.515 |
| September 01, 2026 | 6.330 |
| August 31, 2026 | 6.306 |
| August 28, 2026 | 6.408 |
| August 27, 2026 | 6.583 |
| August 26, 2026 | 6.727 |
| August 25, 2026 | 6.727 |
| August 24, 2026 | 6.727 |
| August 21, 2026 | 6.879 |
| August 20, 2026 | 6.673 |
| August 19, 2026 | 6.660 |
| August 18, 2026 | 6.476 |
| August 17, 2026 | 7.074 |
| August 14, 2026 | 6.778 |
| Date | Value |
|---|---|
| August 13, 2026 | 6.622 |
| August 12, 2026 | 6.769 |
| August 11, 2026 | 6.869 |
| August 10, 2026 | 6.677 |
| August 07, 2026 | 6.874 |
| August 06, 2026 | 6.630 |
| August 05, 2026 | 6.007 |
| August 04, 2026 | 6.422 |
| August 03, 2026 | 6.269 |
| July 31, 2026 | 6.201 |
| July 30, 2026 | 6.458 |
| July 29, 2026 | 6.374 |
| July 28, 2026 | 6.574 |
| July 27, 2026 | 6.572 |
| July 24, 2026 | 6.654 |
| July 23, 2026 | 6.728 |
| July 22, 2026 | 7.064 |
| July 21, 2026 | 7.524 |
| July 20, 2026 | 7.097 |
| July 17, 2026 | 7.249 |
| July 16, 2026 | 7.249 |
| July 15, 2026 | 7.957 |
| July 14, 2026 | 7.701 |
| July 13, 2026 | 7.631 |
| July 10, 2026 | 8.241 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.477 |
| Alnylam Pharmaceuticals, Inc. | 24.12 |
| Anika Therapeutics, Inc. | 2.020 |
| Savara, Inc. | 7.799 |
| Vericel Corp. | 5.466 |
Price to Book Value Related Metrics
| Price | 0.791 |
| Earnings Yield | -217.2% |
| Market Cap | 67.84M |